Explore the complete record of transactions filed by Apeiron Investment Group Ltd.. Director active across 5 companies, notably ATAI Life Sciences N.V.. Aggregated, 27 disclosures have been logged. Split: 21 buys · 2 sells. Total volume traded: €59.3m. History available since 22 June 2021. The latest transaction was disclosed on 2 September 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Apeiron Investment Group Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Apeiron Investment Group Ltd. has filed 19 disclosures between 2021-06-24 and 2026-07-24. In this sample of recent filings, buys total EUR 52347076 and sells total EUR 3677188, mainly in ATAI Life Sciences N.V., with also transactions in Sensei Biotherapeutics, Inc., Enhanced Group Inc., BIONOMICS LTD/ADR and Alto Neuroscience, Inc.; no primary role is stated, but Enhanced Group Inc. is listed with the role of Director.